SARS-CoV-2 ORF7a antibody (AA 16-111)
-
- Target See all SARS-CoV-2 ORF7a products
- SARS-CoV-2 ORF7a
-
Binding Specificity
- AA 16-111
- Reactivity
- SARS Coronavirus (SARS-CoV)
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This SARS-CoV-2 ORF7a antibody is un-conjugated
- Application
- Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
- Cross-Reactivity
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
- Purification
- Affinity purified by Protein G.
- Immunogen
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
- Clone
- 3C9
- Isotype
- IgG1
-
-
- Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Comment
-
Positive Control: ORF7a-transfected 293T cell
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS, No Preservative
- Preservative
- Without preservative
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- SARS-CoV-2 ORF7a
- Abstract
- SARS-CoV-2 ORF7a Products
- Synonyms
- ORF7a protein antibody, ORF7a antibody
- Background
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
-